{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:40:18Z","timestamp":1792798818114,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.kint.2026.09.029","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:04:01Z","timestamp":1792796641000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry"],"prefix":"10.1016","author":[{"given":"Anila","family":"Cara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman Deep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.f","family":"Vargas-Brochero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Juanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Garcia","family":"Majado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilario","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Laxamana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Monteiro","family":"Pereira Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samih H.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.09.029_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2026.09.029_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.0000000000000242","article-title":"Treatment of IgA Nephropathy: A Rapidly Evolving Field","volume":"35","author":"El Karoui","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/j.ajkd.2025.09.029","article-title":"The Roles of A Proliferation-Inducing Ligand (APRIL) and B-Cell Activating Factor (BAFF) in IgA Nephropathy","volume":"87","author":"Reily","year":"2026","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.09.029_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1681\/ASN.2016040433","article-title":"A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy","volume":"28","author":"Haas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2215\/CJN.0000000000000398","article-title":"Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis","volume":"19","author":"Barbour","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638309","article-title":"Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients","volume":"12","author":"Chiu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.09.029_bib9","article-title":"CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy","author":"Zhang","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.kint.2025.07.038","article-title":"Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis","volume":"108","author":"Novak","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib11","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.ekir.2025.07.005","article-title":"Proteomic Analysis of Circulating IgA1-Containing Immune Complexes in Patients with IgA Nephropathy","volume":"10","author":"Cunningham","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.09.029_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.kint.2026.09.029_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/nep.14342","article-title":"IgA nephropathy: Correlation between pathologic findings and complement activation","volume":"29","author":"Haas","year":"2024","journal-title":"Nephrology"},{"key":"10.1016\/j.kint.2026.09.029_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151572","article-title":"Current Biomarkers of IgA Nephropathy","volume":"44","author":"Kamal","year":"2024","journal-title":"Semin Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.kint.2026.09.029_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/nep.14347","article-title":"Utilizing complement inhibition in IgA nephropathy","volume":"29","author":"Lafayette","year":"2024","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2026.09.029_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2019.07.017","article-title":"The role of complement in IgA nephropathy","volume":"114","author":"Tortajada","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2026.09.029_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current Understanding of the Role of Complement in IgA Nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","article-title":"The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy","volume":"10","author":"Rizk","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.09.029_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/ndt\/gfaf200","article-title":"In situ assessment of glomerular C3\/C5 convertases indicates ongoing complement activation in IgA nephropathy","volume":"41","author":"Obrecht","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.09.029_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2600743","article-title":"Iptacopan in IgA Nephropathy - Final 24-Month Data","author":"Barratt","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.09.029_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2026.03.003","article-title":"Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentary","author":"Rovin","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.kint.2025.11.017","article-title":"A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy","volume":"109","author":"Barbour","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.kint.2025.12.015","article-title":"The expanding role of complement inhibitors in the treatment of IgA nephropathy","volume":"109","author":"Caravaca-Font\u00e1n","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib24","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.ajt.2025.08.015","article-title":"Targeting the alternative complement pathway by iptacopan abrogates C3 and strongly reduces C5b-9 deposition within glomeruli in IgA nephropathy recurrence after kidney transplantation","volume":"25","author":"Sanna","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2026.09.029_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2026.02.029","article-title":"Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","author":"Floege","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2026.03.003","article-title":"Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary","author":"Rovin","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib27","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1016\/j.ekir.2025.09.043","article-title":"Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis","volume":"10","author":"Fervenza","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.09.029_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.kint.2024.07.031","article-title":"A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry","volume":"106","author":"Vrana","year":"2024","journal-title":"Kidney International"},{"key":"10.1016\/j.kint.2026.09.029_bib29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.kint.2024.02.013","article-title":"Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy","volume":"105","author":"Madden","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/pr401017h","article-title":"Accurate label-free protein quantitation with high- and low-resolution mass spectrometers","volume":"13","author":"Krey","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.kint.2026.09.029_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jprot.2019.03.005","article-title":"Label-free absolute protein quantification with data-independent acquisition","volume":"200","author":"He","year":"2019","journal-title":"J Proteomics"},{"key":"10.1016\/j.kint.2026.09.029_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib33","article-title":"IgA: Structure, Function, and Developability","volume":"8","author":"de Sousa-Pereira","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.kint.2026.09.029_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2026.02.018","article-title":"Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy","author":"Li","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib35","first-page":"61","article-title":"Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy","volume":"33","author":"Komatsu","year":"1983","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2026.09.029_bib36","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2018111156","article-title":"Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1","volume":"30","author":"Rizk","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib37","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.3390\/jcm12237361","article-title":"Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores","volume":"12","author":"Rizk","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.kint.2026.09.029_bib38","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2012010053","article-title":"Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy","volume":"23","author":"Berthoux","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.kint.2026.05.014","article-title":"Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy","volume":"110","author":"Zhang","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.09.029_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2026.09.029_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12014-023-09409-w","article-title":"Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis","volume":"20","author":"Kaga","year":"2023","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.kint.2026.09.029_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/nep.13676","article-title":"Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry","volume":"25","author":"Kawata","year":"2020","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2026.09.029_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-017-9165-x","article-title":"Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy","volume":"14","author":"Paunas","year":"2017","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.kint.2026.09.029_bib44","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.ajkd.2025.07.023","article-title":"Complement Inhibition in Immunoglobulin A Nephropathy: A Mini-Review","volume":"87","author":"Teh","year":"2026","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.kint.2026.09.029_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2006.06.017","article-title":"Structural insights into the central complement component C3","volume":"44","author":"Janssen","year":"2007","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.kint.2026.09.029_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ndt\/gfw290","article-title":"Characterization of C3 in C3 glomerulopathy","volume":"32","author":"Sethi","year":"2016","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.kint.2026.09.029_bib48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2215\/CJN.0000000943","article-title":"Complement Profiling in Glomerular Disease: Insights from Laser Microdissection and Mass Spectrometry","volume":"21","author":"Sethi","year":"2026","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.09.029_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ekir.2025.09.047","article-title":"Dual Role of Factor H-Related Protein 1 in IgA Nephropathy Kidney Injury","volume":"11","author":"Kang","year":"2026","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.09.029_bib50","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826008501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826008501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:04:06Z","timestamp":1792796646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826008501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0085253826008501"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.09.029","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}